Skip to main content

Gerard Marti Aguasca

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Gerard Marti Aguasca

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Antiagregación en infarto con elevación del ST revascularizado con stent: Efectividad y variabilidad de la práctica clínica. Subproyecto 1

IP: Ignacio Ferreira González
Collaborators: Aida Ribera Sole, Gerard Marti Aguasca, Jordi Bañeras Rius, Bruno García del Blanco
Funding agency: Instituto de Salud Carlos III
Funding: 80465
Reference: PI13/00399
Duration: 01/01/2014 - 30/06/2018

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Eficacia y seguridad de la doble antiagregación comparada con la combinación de anticoagulación oral+doble antiagregación en pacientes con fibrilación auricular de bajo-moderado riesgo sometidos a la implantación de un stent coronario

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Bruno García del Blanco, Pilar Tornos Mas
Funding agency: Ministerio Sanidad
Funding: 64900
Reference: EC11-473
Duration: 01/01/2012 - 31/12/2014

Características inmunohistoquímicas y moleculares del trombo resistente a la fibrinolisis

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta
Funding agency: Instituto de Salud Carlos III
Funding: 57475
Reference: PI09/01014
Duration: 01/01/2010 - 30/06/2014

Related news

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.

Related professionals

Iratxe Ugarriza Serrano

Iratxe Ugarriza Serrano

Neurovascular Diseases
Read more
Josefa Mª Heredia Montiel

Josefa Mª Heredia Montiel

Administration and Management
Physiology and Pathophysiology of the Digestive Tract
Read more
Mª Carmen López  Arribas

Mª Carmen López Arribas

Research technician
Molecular Medical Imaging
Read more
Teresa Vendrell Bayona

Teresa Vendrell Bayona

Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.